Efficacy of VAS203 (Ronopterin) in Patients With Moderate and Severe Traumatic Brain Injury (NOSTRA-III)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02794168
Recruitment Status : Recruiting
First Posted : June 8, 2016
Last Update Posted : December 17, 2018
ICON plc
Information provided by (Responsible Party):
Vasopharm GmbH